Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients-Reference-Cited by-同舟云学术

Molecular diagnostic tests to predict the risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients

Published:2015-02 Issue:1 Volume:29 Page:54-62
ISSN:0890-8508
Container-title:Molecular and Cellular Probes
language:en
Short-container-title:Molecular and Cellular Probes

Author:

Rossi Francesca,Newsome Scott D.,Viscidi Raphael^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference68 articles.

1. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease;Astrom;Brain,1958

2. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993;Selik;J Infect Dis,1997

3. Progressive multifocal leukoencephalopathy deaths in the USA, 1979–2005;Christensen;Neuroepidemiology,2010

4. Progressive multifocal leukoencephalopathy and other forms of JC virus disease;Brew;Nat Rev Neurol,2010

5. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases;Clifford;Lancet Neurol,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

2. Mutations in the John Cunningham virus VP1 gene could predispose to the development of progressive multifocal leukoencephalopathy in multiple sclerosis patients undergoing treatment with natalizumab;Multiple Sclerosis and Related Disorders;2021-11

3. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue;Journal of Clinical Apheresis;2019-06

4. An integrated QSAR modeling approach to explore the structure–property and selectivity relationships of N-benzoyl-l-biphenylalanines as integrin antagonists;Molecular Diversity;2017-11-17

5. Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy;Viral Immunology;2017-10